UNRESECTABLE SOLID TUMOR
Clinical trials for UNRESECTABLE SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE SOLID TUMOR trials appear
Sign up with your email to follow new studies for UNRESECTABLE SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets 'Undruggable' cancer mutation
Disease control Recruiting nowThis study is testing a new drug called FMC-376 for adults with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find a safe and effective dose and to see if the drug can shrink or control the tumors. The trial is for people whose …
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Frontier Medicines Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New precision drug targets Cancer's genetic weakness
Disease control Recruiting nowThis is a first-in-human study testing a new targeted drug called RLY-2608. It aims to find a safe and effective dose for patients with advanced solid tumors or breast cancer that have a specific genetic mutation called PIK3CA. The study will test the drug by itself and in combin…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Radioactive nanoparticles target Tough-to-Treat cancers in new trial
Disease control Recruiting nowThis is a first-in-human study testing a new experimental drug called 177Lu-SN201 in adults with advanced solid tumors that have progressed despite standard treatments. The drug is a radioactive nanoparticle designed to accumulate in tumors. The main goals are to find a safe and …
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Spago Nanomedical AB • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First-of-its-Kind cancer drug targets 'Guardian Gene' mutation
Disease control Recruiting nowThis is a first-in-human study testing a new drug called CLSP-1025 for adults with advanced solid tumors that have a specific genetic change called the p53 R175H mutation. The main goals are to find a safe dose and see if the drug can help control the cancer. The drug works by en…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo tested in fight against Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of combining two targeted cancer drugs, pemigatinib and afatinib, in people with advanced solid tumors that have specific genetic changes and have stopped responding to standard treatments. The main goals are …
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New 'Peaks and Valleys' radiation aims to shrink tough tumors with fewer side effects
Symptom relief Recruiting nowThis early study is testing a specialized form of proton radiation called 'GRID' for patients with large, inoperable, or metastatic tumors that need treatment to relieve symptoms. The technique delivers radiation in a precise 'peaks and valleys' pattern, which researchers hope wi…
Matched conditions: UNRESECTABLE SOLID TUMOR
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC